New antibody aims to tame rare liver disease
Disease control
Completed
This trial tests an experimental antibody drug called CM-101 in adults with primary sclerosing cholangitis (PSC), a rare liver disease. The drug targets a protein called CCL24 to potentially reduce inflammation and scarring. Participants receive either CM-101 or a placebo by intr…
Phase: PHASE2 • Sponsor: ChemomAb Ltd. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC